Detailed Information for C00235

Basic information about inhibitors

IPAD-DB ID C00235
Name Kuwanon G
Category Natural compounds
2D Structure
3D Structure
Molecular Formula C 4 0 H 3 6 O 1 1
Molecular Weight 692.7g/mol
IUPAC Name 8-[(1S, 5R, 6S)-6-(2, 4-dihydroxybenzoyl)-5-(2, 4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-2-(2, 4-dihydroxyphenyl)-5, 7-dihydroxy-3-(3-methylbut-2-enyl)chromen-4-one
InChI InChI=1S/C40H36O11/c1-18(2)4-8-26-38(50)36-33(48)17-32(47)35(40(36)51-39(26)25-11-7-22(43)16-31(25)46)28-13-19(3)12-27(23-9-5-20(41)14-29(23)44)34(28)37(49)24-10-6-21(42)15-30(24)45/h4-7, 9-11, 13-17, 27-28, 34, 41-48H, 8, 12H2, 1-3H3/t27-, 28-, 34-/m0/s1
InChIKey APPXYONGBIXGRO-AIQWNVMPSA-N
Canonical SMILES CC1=CC(C(C(C1)C2=C(C=C(C=C2)O)O)C(=O)C3=C(C=C(C=C3)O)O)C4=C(C=C(C5=C4OC(=C(C5=O)CC=C(C)C)C6=C(C=C(C=C6)O)O)O)O
PubChem CID 5281667
DrugBank Accession Number -
CAS Registry Number 75629-19-5

Biological activity data

Ki -
EC50 28.7 μM(AChE), 11.9 μM(BChE), 1.4 μM(BACE1)
IC50 37.07 ± 0.35μg/mL(AChE), 15.33 ± 0.30 μg/mL(BChE), 1.01 ± 0.04 μg/mL((BACE1)
Inhibition -
Toxicity -
ROS(reactive oxygen species) -
Metal Chelating -
BBB(blood-brain barrier) -
Target Protein β-site amyloid precursor protein cleaving enzyme 1 (BACE1)
Effects -
Research Models In Vitro, Molecular-docking
Main Source From the root bark of Morus alba L.
Ref. Link

Physicochemical properties

Molecular Weight(Computed by SwissADME) 692.71
Hac(Computed by SwissADME) 51
Volume(Computed by ADMETlab 2.0) 700.93
Density(Computed by ADMETlab 2.0) 0.988
nRing(Computed by ADMETlab 2.0) 6
MaxRing(Computed by ADMETlab 2.0) 10
nHet(Computed by ADMETlab 2.0) 11
fChar(Computed by ADMETlab 2.0) 0
nRig(Computed by ADMETlab 2.0) 38
Flexibility(Computed by ADMETlab 2.0) 0.184
Stero Centers(Computed by ADMETlab 2.0) 3
LogS(Computed by ADMETlab 2.0) -3.358
LogD(Computed by ADMETlab 2.0) 3.273

ADMET properties

logP(Computed by ADMETlab 2.0) 7.33
TPSA(Computed by SwissADME) 209.12 Ų
Hbond Acceptor(Computed by SwissADME) 11
Hbond Donor(Computed by SwissADME) 8
Rotatable Bonds(Computed by SwissADME) 7

Pharmacokinetics

GI Absorption(Computed by SwissADME) Low
BBB(blood-brain barrier) Permeant(Computed by SwissADME) No
P-gp Substrate(Computed by SwissADME) No
CYP1A2 Inhibitor(Computed by SwissADME) No
CYP2C19 Inhibitor(Computed by SwissADME) No
CYP2C9 Inhibitor(Computed by SwissADME) No
CYP2D6 Inhibitor(Computed by SwissADME) No
CYP3A4 Inhibitor(Computed by SwissADME) No
log Kp(Skin Permeation)(Computed by SwissADME) -5.34 cm/s

Druglikeness

Lipinski(Computed by SwissADME) No, 3 violations: MW>500, NorO>10, NHorOH>5
Ghose(Computed by SwissADME) No, 4 violations: MW>480, WLOGP>5.6, MR>130, #atoms>70
Veber(Computed by SwissADME) No, 1 violation: TPSA>140
Egan(Computed by SwissADME) No, 2 violations: WLOGP>5.88, TPSA>131.6
Muegge(Computed by SwissADME) No, 5 violations: MW>600, XLOGP3>5, TPSA>150, H-acc>10, H-don>5
Bioavailability Score(Computed by SwissADME) 0.17